Endothelial progenitor cells: A source for therapeutic vasculogenesis?

被引：55

作者：

Rumpold, H ^{[1
]}

Wolf, D ^{[1
]}

Koeck, R ^{[1
]}

Gunsilius, E ^{[1
]}

机构：

[1] Med Univ Innsbruck, Dept Hematol & Oncol, Tumor Biol & Angiogensis Lab, A-6020 Innsbruck, Austria

来源：

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 2004年 / 8卷 / 04期

关键词：

angiogenesis; vasculogenesis;

D O I：

10.1111/j.1582-4934.2004.tb00475.x

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Angiogenesis has been defined as sprouting of blood vessels from pre-existing vascular structures. Risau and co-workers defined the term vasculogenesis while studying the formation of new blood vessels in embryoid bodies. This process is characterized by the recruitment of endothelial progenitor cells (EPC) to sites of new vessel formation with subsequent differentiation of EPC into mature endothelial cells, extensively proliferating in situ. Data from recent years provided evidence that EPC also exist in the adult and contribute to new vessel formation, a process called postnatal vasculogenesis. The existence of EPC has been convincingly shown in both, animals and humans. They represent a perfect cellular progenitor cell population for the ex vivo generation of EC, which in turn serve as cellular source for therapeutic vasculogenesis or tumor targeting. This review provides an overview on this hot topic of cellular-based therapeutic concepts and the therapeutic potential of ex vivo generated EPC.

引用

页码：509 / 518

页数：10

共 57 条

[1] Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction -: (TOPCARE-AMI) [J].